drug

ATRN-119

1 story · latest Aug 12, 2026

Status: Investigational
Trials: 1 registered trial in coverage

Relationships

Developed by Aprea Therapeutics

Timeline

Aprea reports Q2 2026 results, faster enrollment in APR-1051 trial

Aug 12Clinical readoutAPR-1051 Aprea Therapeutics

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.